About Angiotensinogen
Angiotensinogen (AGT) is a protein
from Homo sapiens identified by UniProt accession
P01019, 476 residues long.
MolForge cross-references it against 0 known binders and
1,137 disease associations.
Target properties
| Protein name | Angiotensinogen |
| UniProt accession | P01019 |
| Gene | AGT |
| Organism | Homo sapiens |
| Length | 476 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1137)
Diseases linked to this target (Open Targets).
- renal tubular dysgenesis · score 0.68
- renal tubular dysgenesis of genetic origin · score 0.64
- hypertension · score 0.62
- essential hypertension, genetic · score 0.60
- systolic blood pressure · score 0.47
- diastolic blood pressure · score 0.46
- blood protein measurement · score 0.40
- cardiovascular disease · score 0.39
- congenital anomaly of kidney and urinary tract · score 0.37
- mean arterial pressure · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P01019-F1 | alphafold | PREDICTED | 86.45 | — |
Amino-acid sequence (476 residues)
MAPAGVSLRA TILCLLAWAG LAAGDRVYIH PFHLVIHNES TCEQLAKANA GKPKDPTFIP APIQAKTSPV DEKALQDQLV LVAAKLDTED KLRAAMVGML ANFLGFRIYG MHSELWGVVH GATVLSPTAV FGTLASLYLG ALDHTADRLQ AILGVPWKDK NCTSRLDAHK VLSALQAVQG LLVAQGRADS QAQLLLSTVV GVFTAPGLHL KQPFVQGLAL YTPVVLPRSL DFTELDVAAE KIDRFMQAVT GWKTGCSLMG ASVDSTLAFN TYVHFQGKMK GFSLLAEPQE FWVDNSTSVS VPMLSGMGTF QHWSDIQDNF SVTQVPFTES ACLLLIQPHY ASDLDKVEGL TFQQNSLNWM KKLSPRTIHL TMPQLVLQGS YDLQDLLAQA ELPAILHTEL NLQKLSNDRI RVGEVLNSIF FELEADEREP TESTQQLNKP EVLEVTLNRP FLFAVYDQSA TALHFLGRVA NPLSTA
Explore Angiotensinogen with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets